Fitting a hormonal intrauterine device (IUD) during surgery to help manage heavy menstrual bleeding reduces a woman's risk of ...
Aspivix, a medical technology company dedicated to modernizing gynecology with gentle in mind, and Afaxys, today announced an ...
No new safety signals identified during additional three years of extended use; Organon holds exclusive global licensing rights to MIUDELLA; JERSEY CITY, N.J.--(BUSINESS WIRE)--Oc ...
The political parties in the Greenlandic parliament Inatsisartut support the security agreement that Greenland, Denmark and the United States entered into in September. At the same time, several of ...
Greenland’s government is open to returning to UTC-3 and abolishing daylight saving time. Greenland’s largest business organisation, Sulisitsisut, has warned against proposed change, according to ...
Heavy menstrual bleeding is a challenging condition that, when refractory to conventional treatment, frequently culminates in hysterectomy. Endometrial ablation offers an effective, uterus-sparing ...
Organon reports interim six-year MIUDELLA Phase 3 results, including a 3.9% cumulative pregnancy rate, with an FDA decision ...
MIUDELLA's six-year pregnancy rate was 3.9 per cent; FDA action on extending its three-year label is expected in the second ...
A new California law that was introduced following a Team 10 investigation will prevent some physicians who have a history of ...
Christopher Groux is a Testing Methodologies Manager, editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and ...
Life science investment firm KD Ventures' portfolio company Umecrine Cognition has received a preliminary patent allowance from the U.S. Patent and Trademark Office, USPTO, for the treatment of ...
John Öhd continues as senior adviser to KD Ventures FW Oct. 15 KDventures AB Announces Transition of John Öhd from Chief Scientific Officer to Senior Advisor CI Oct. 15 KD Ventures portfolio company ...